Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Our clinicians provide GLP-1guided medical weight-loss care across three Central Florida locations
Taking a step back, Novo Nordisks defeat of Mylans IPR challenge for the 343 patent cannot be underestimated
Synapse is an oral cognitive optimization protocol built around Dihexa, a synthetic peptide derived from angiotensin IV that crosses the blood-brain barrier to promote the formation of new synaptic connections
See important warnings & safety info about these medications
FDAs concerns with unapproved GLP-1 drugs used for weight loss, United States Food and Drug Administration (2024) FDA approves first oral GLP-1 treatment for Type 2 diabetes, United States Food and Drug Administration (2019) Semaglutide for Type 2 diabetes, CADTH Health Technology Review (2023) Anti-inflammatory benefits of semaglutide: State of the art, Journal of Clinical & Translational Endocrinology (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
As a result, getting participants excited about this study was no problem at all
